• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用中医药进行癌症预防和治疗的新进展。

Developments in cancer prevention and treatment using traditional Chinese medicine.

机构信息

Department of Oncology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China.

出版信息

Front Med. 2011 Jun;5(2):127-33. doi: 10.1007/s11684-011-0137-7. Epub 2011 Jun 22.

DOI:10.1007/s11684-011-0137-7
PMID:21695616
Abstract

Through the joint efforts of several generations of practitioners in traditional Chinese medicine (TCM) and integrated medicine of oncology, we have made some achievements in cancer treatment using TCM in over 50 years, including treatment concepts, methods, and basic and clinical research. Currently, TCM plays an indispensable role in cancer prevention and treatment. However, we also clearly recognize that there are some issues that have yet to be resolved. In the future, cancer treated with TCM will face unprecedented opportunities and challenges. This article reviews the developments of TCM in the treatment of cancer.

摘要

经过几代中医和肿瘤整合医学从业者的共同努力,50 多年来,我们在中医药治疗癌症方面取得了一些成就,包括治疗理念、方法以及基础和临床研究。目前,中医药在癌症的防治中发挥着不可或缺的作用。但我们也清醒地认识到,仍有一些问题有待解决。今后,中医药治疗癌症将面临前所未有的机遇和挑战。本文对中医药治疗癌症的发展进行综述。

相似文献

1
Developments in cancer prevention and treatment using traditional Chinese medicine.利用中医药进行癌症预防和治疗的新进展。
Front Med. 2011 Jun;5(2):127-33. doi: 10.1007/s11684-011-0137-7. Epub 2011 Jun 22.
2
Practices, challenges, and opportunities: HIV/AIDS treatment with traditional Chinese medicine in China.实践、挑战与机遇:中国的艾滋病中医治疗
Front Med. 2011 Jun;5(2):123-6. doi: 10.1007/s11684-011-0124-z. Epub 2011 Jun 22.
3
Traditional Chinese medicine research in the post-genomic era: good practice, priorities, challenges and opportunities.后基因组时代的中医药研究:良好实践、重点、挑战和机遇。
J Ethnopharmacol. 2012 Apr 10;140(3):458-68. doi: 10.1016/j.jep.2012.02.028. Epub 2012 Feb 23.
4
Integrative medicine in the era of cancer immunotherapy: Challenges and opportunities.癌症免疫治疗时代的整合医学:挑战与机遇。
J Integr Med. 2021 Jul;19(4):291-294. doi: 10.1016/j.joim.2021.03.005. Epub 2021 Mar 18.
5
Effectiveness of Combined Treatment with Traditional Chinese Medicine and Western Medicine on the Prognosis of Patients with Breast Cancer.中药联合西药治疗对乳腺癌患者预后的影响。
J Altern Complement Med. 2020 Sep;26(9):833-840. doi: 10.1089/acm.2019.0200.
6
Current Usage of Traditional Chinese Medicine in the Management of Breast Cancer: A Practitioner's Perspective.中医在乳腺癌管理中的当前应用:从业者视角
Integr Cancer Ther. 2016 Sep;15(3):335-42. doi: 10.1177/1534735415607656. Epub 2015 Sep 29.
7
Integration of traditional Chinese medicine and Western medicine in the era of precision medicine.精准医学时代的中西医结合。
J Integr Med. 2017 Jan;15(1):1-7. doi: 10.1016/S2095-4964(17)60314-5.
8
Exploring the influence of Traditional Chinese Medicine on self-care among Chinese cancer patients.探索中医药对中国癌症患者自我护理的影响。
Eur J Oncol Nurs. 2014 Oct;18(5):445-51. doi: 10.1016/j.ejon.2014.05.005. Epub 2014 Jun 20.
9
Traditional Chinese medicine integrated with chemotherapy for stage IV non-surgical gastric cancer: a retrospective clinical analysis.中药联合化疗治疗Ⅳ期不可手术胃癌的回顾性临床分析。
J Integr Med. 2017 Nov;15(6):469-475. doi: 10.1016/S2095-4964(17)60377-7.
10
Good practice in reviewing and publishing studies on herbal medicine, with special emphasis on traditional Chinese medicine and Chinese materia medica.草药研究的审查和发表的良好实践,特别强调传统中药和中药。
J Ethnopharmacol. 2012 Apr 10;140(3):469-75. doi: 10.1016/j.jep.2012.01.038. Epub 2012 Feb 11.

引用本文的文献

1
Network pharmacology and experimental analysis reveal Ethyl caffeate delays osimertinib resistance in lung cancer by suppression of MET.网络药理学与实验分析表明,咖啡酸乙酯通过抑制MET延缓肺癌中奥希替尼耐药性。
Cancer Cell Int. 2025 Mar 15;25(1):99. doi: 10.1186/s12935-025-03690-5.
2
with the homology of medicine and food: a review of active ingredients, anticancer mechanisms, pharmacokinetics, quality control, toxicity and applications.药食同源:活性成分、抗癌机制、药代动力学、质量控制、毒性及应用综述
Front Oncol. 2024 Sep 9;14:1446328. doi: 10.3389/fonc.2024.1446328. eCollection 2024.
3
Pyroptosis in cancer treatment and prevention: the role of natural products and their bioactive compounds.

本文引用的文献

1
[A randomized, prospective, multi-centre clinical trial of NP regimen (vinorelbine+cisplatin) plus Gensing Rg3 in the treatment of advanced non-small cell lung cancer patients].
Zhongguo Fei Ai Za Zhi. 2006 Jun 20;9(3):254-8. doi: 10.3779/j.issn.1009-3419.2006.03.09.
2
Cucurbitacin E, a tetracyclic triterpenes compound from Chinese medicine, inhibits tumor angiogenesis through VEGFR2-mediated Jak2-STAT3 signaling pathway.葫芦素 E 是一种来自中药的四环三萜类化合物,通过 VEGFR2 介导的 Jak2-STAT3 信号通路抑制肿瘤血管生成。
Carcinogenesis. 2010 Dec;31(12):2097-104. doi: 10.1093/carcin/bgq167. Epub 2010 Aug 23.
3
Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.三氧化二砷通过直接结合 PML 来控制 PML-RARα 癌蛋白的命运。
天然产物及其生物活性化合物在癌症治疗和预防中的细胞焦亡作用
Med Oncol. 2024 Jan 28;41(3):66. doi: 10.1007/s12032-023-02293-2.
4
Moxibustion attenuates liver metastasis of colorectal cancer by regulating gut microbial dysbiosis.艾灸通过调节肠道微生物失调减轻结直肠癌肝转移。
Am J Cancer Res. 2023 Feb 15;13(2):394-407. eCollection 2023.
5
Integration strategy of network pharmacology in Traditional Chinese Medicine: a narrative review.网络药理学在中医药中的整合策略:综述。
J Tradit Chin Med. 2022 Jun;42(3):479-486. doi: 10.19852/j.cnki.jtcm.20220408.003.
6
Comparative efficacy of 10 Chinese herbal injections combined with GP regimen chemotherapy for patients with advanced NSCLC a systematic review and network meta-analysis.10种中药注射剂联合GP方案化疗治疗晚期非小细胞肺癌患者的疗效比较:一项系统评价与网状Meta分析
J Cancer. 2022 Jan 1;13(2):465-480. doi: 10.7150/jca.66410. eCollection 2022.
7
Effects of a Chlorogenic Acid-Containing Herbal Medicine (LAS) on Colon Cancer.一种含绿原酸草药(LAS)对结肠癌的影响。
Evid Based Complement Alternat Med. 2021 Aug 20;2021:9923467. doi: 10.1155/2021/9923467. eCollection 2021.
8
Ethanol Extracts of Regulate Ovarian Cancer Cell Proliferation, Apoptosis, and Epithelial-to-Mesenchymal Transition (EMT) via the ROS-Mediated p53 Pathway.乙醇提取物通过 ROS 介导的 p53 通路调节卵巢癌细胞增殖、凋亡和上皮间质转化(EMT)。
J Immunol Res. 2021 Apr 1;2021:5569354. doi: 10.1155/2021/5569354. eCollection 2021.
9
Myricetin induces apoptosis and autophagy by inhibiting PI3K/Akt/mTOR signalling in human colon cancer cells.杨梅素通过抑制人结肠癌细胞中的 PI3K/Akt/mTOR 信号通路诱导细胞凋亡和自噬。
BMC Complement Med Ther. 2020 Jul 6;20(1):209. doi: 10.1186/s12906-020-02965-w.
10
Study on the Anticancer Effect of an Astragaloside- and Chlorogenic Acid-Containing Herbal Medicine (RLT-03) in Breast Cancer.含黄芪甲苷和绿原酸的草药(RLT - 03)对乳腺癌抗癌作用的研究
Evid Based Complement Alternat Med. 2020 Jun 10;2020:1515081. doi: 10.1155/2020/1515081. eCollection 2020.
Science. 2010 Apr 9;328(5975):240-3. doi: 10.1126/science.1183424.
4
Chinese herbal medicines for induction of remission in advanced or late gastric cancer.用于晚期胃癌诱导缓解的中草药。
Cochrane Database Syst Rev. 2010 Jan 20(1):CD005096. doi: 10.1002/14651858.CD005096.pub2.
5
Chinese herbal medicines for esophageal cancer.用于食管癌的中草药
Cochrane Database Syst Rev. 2009 Oct 7(4):CD004520. doi: 10.1002/14651858.CD004520.pub6.
6
Herbal extract of Wedelia chinensis attenuates androgen receptor activity and orthotopic growth of prostate cancer in nude mice.蟛蜞菊的草药提取物可减弱裸鼠体内雄激素受体活性并抑制前列腺癌原位生长。
Clin Cancer Res. 2009 Sep 1;15(17):5435-44. doi: 10.1158/1078-0432.CCR-09-0298. Epub 2009 Aug 18.
7
Global detection and identification of nontarget components from herbal preparations by liquid chromatography hybrid ion trap time-of-flight mass spectrometry and a strategy.通过液相色谱-混合离子阱飞行时间质谱法对草药制剂中的非目标成分进行全球检测和鉴定及一种策略。
Anal Chem. 2008 Nov 1;80(21):8187-94. doi: 10.1021/ac801356s. Epub 2008 Sep 17.
8
Artesunate derived from traditional Chinese medicine induces DNA damage and repair.源自中药的青蒿琥酯可诱导DNA损伤与修复。
Cancer Res. 2008 Jun 1;68(11):4347-51. doi: 10.1158/0008-5472.CAN-07-2970.
9
Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials.基于黄芪的中药与铂类化疗治疗晚期非小细胞肺癌:随机试验的荟萃分析
J Clin Oncol. 2006 Jan 20;24(3):419-30. doi: 10.1200/JCO.2005.03.6392.
10
Triptolide, a constituent of immunosuppressive Chinese herbal medicine, is a potent suppressor of dendritic-cell maturation and trafficking.雷公藤内酯醇是一种具有免疫抑制作用的中草药成分,是树突状细胞成熟和迁移的有效抑制剂。
Blood. 2005 Oct 1;106(7):2409-16. doi: 10.1182/blood-2005-03-0854. Epub 2005 Jun 14.